NCT00665054View on ClinicalTrials.gov

BAY38-9456, 5/10/20mg, vs.Placebo in Erectile Dysfunction

PHASE4CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
Erectile Dysfunction
Interventions
DRUG

Levitra (Vardenafil, BAY38-9456)

5, 10, or 20 mg Vardenafil tablets orally prior to sexual activity

DRUG

Placebo

Matching placebo tablets orally prior to sexual activity

Trial Locations (8)

34098

Istanbul

34662

Istanbul

35340

Izmir

55139

Samsun

01330

Adana

06100

Ankara

06500

Ankara

07003

Antalya

Sponsors

Lead Sponsor

Bayer

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Bayer

INDUSTRY

NCT00665054 - BAY38-9456, 5/10/20mg, vs.Placebo in Erectile Dysfunction | Biotech Hunter | Biotech Hunter